Arkolith/Insider Trading/SANA/Form 4

Wyrick Susan D.

See RemarksSana Biotechnology, Inc. (SANA) · full profile →Form 4 · filed Mar 10, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 9, 2026Tax withholding(F)1K$3.10$3K196K
Mar 9, 2026Tax withholding(F)3K$3.13$10K197K
Mar 7, 2026Option exercise(M)3K—$0201K
Mar 6, 2026Option exercise(M)10K—$0197K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 7, 2026Option exercise(M)3K—$07K
Mar 6, 2026Option exercise(M)10K—$031K

Transaction Codes

F
Shares withheld for taxes
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001568605-26-000008) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML